#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-8	Aberrant	_
1-2	9-30	structural-functional	_
1-3	31-39	coupling	_
1-4	40-42	in	_
1-5	43-48	adult	_
1-6	49-57	cannabis	_
1-7	58-63	users	_
1-8	64-72	Cellular	_
1-9	73-80	studies	_
1-10	81-89	indicate	_
1-11	90-94	that	_
1-12	95-110	endocannabinoid	_
1-13	111-117	type-1	_
1-14	118-128	retrograde	_
1-15	129-138	signaling	_
1-16	139-144	plays	_
1-17	145-146	a	_
1-18	147-152	major	_
1-19	153-157	role	_
1-20	158-160	in	_
1-21	161-169	synaptic	_
1-22	170-180	plasticity	_
1-23	181-182	.	_

2-1	183-193	Disruption	_
2-2	194-196	of	_
2-3	197-202	these	_
2-4	203-212	processes	_
2-5	213-215	by	_
2-6	216-244	delta-9-tetrahydrocannabinol	_
2-7	245-246	(	_
2-8	247-250	THC	_
2-9	251-252	)	_
2-10	253-258	could	_
2-11	259-266	produce	_
2-12	267-278	alterations	_
2-13	279-285	either	_
2-14	286-288	in	_
2-15	289-299	structural	_
2-16	300-303	and	_
2-17	304-314	functional	_
2-18	315-320	brain	_
2-19	321-333	connectivity	_
2-20	334-336	or	_
2-21	337-339	in	_
2-22	340-345	their	_
2-23	346-357	association	_
2-24	358-360	in	_
2-25	361-369	cannabis	_
2-26	370-371	(	_
2-27	372-374	CB	_
2-28	375-376	)	_
2-29	377-382	users	_
2-30	383-384	.	_

3-1	385-390	Graph	_
3-2	391-400	theoretic	_
3-3	401-411	structural	_
3-4	412-415	and	_
3-5	416-426	functional	_
3-6	427-435	networks	_
3-7	436-440	were	_
3-8	441-450	generated	_
3-9	451-455	with	_
3-10	456-465	diffusion	_
3-11	466-472	tensor	_
3-12	473-480	imaging	http://maven.renci.org/NeuroBridge/neurobridge#MolecularImaging
3-13	481-484	and	_
3-14	485-498	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-15	499-509	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-16	510-517	imaging	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
3-17	518-520	in	_
3-18	521-523	37	_
3-19	524-531	current	_
3-20	532-534	CB	_
3-21	535-540	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
3-22	541-544	and	_
3-23	545-547	31	_
3-24	548-555	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-25	556-565	non-users	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-26	566-567	.	_

4-1	568-571	The	_
4-2	572-579	primary	_
4-3	580-587	outcome	_
4-4	588-596	measures	_
4-5	597-601	were	_
4-6	602-610	coupling	_
4-7	611-618	between	_
4-8	619-629	structural	_
4-9	630-633	and	_
4-10	634-644	functional	_
4-11	645-657	connectivity	_
4-12	658-659	,	_
4-13	660-666	global	_
4-14	667-674	network	_
4-15	675-690	characteristics	_
4-16	691-692	,	_
4-17	693-704	association	_
4-18	705-712	between	_
4-19	713-716	the	_
4-20	717-725	coupling	_
4-21	726-729	and	_
4-22	730-737	network	_
4-23	738-748	properties	_
4-24	749-750	,	_
4-25	751-754	and	_
4-26	755-763	measures	_
4-27	764-766	of	_
4-28	767-776	rich-club	_
4-29	777-789	organization	_
4-30	790-791	.	_

5-1	792-813	Structural-functional	_
5-2	814-822	coupling	_
5-3	823-826	was	_
5-4	827-835	globally	_
5-5	836-845	preserved	_
5-6	846-853	showing	_
5-7	854-855	a	_
5-8	856-864	positive	_
5-9	865-876	association	_
5-10	877-879	in	_
5-11	880-887	current	_
5-12	888-890	CB	_
5-13	891-896	users	_
5-14	897-898	.	_

6-1	899-906	However	_
6-2	907-908	,	_
6-3	909-912	the	_
6-4	913-918	users	_
6-5	919-922	had	_
6-6	923-932	disrupted	_
6-7	933-945	associations	_
6-8	946-953	between	_
6-9	954-975	structural-functional	_
6-10	976-984	coupling	_
6-11	985-988	and	_
6-12	989-996	network	_
6-13	997-1008	topological	_
6-14	1009-1024	characteristics	_
6-15	1025-1026	,	_
6-16	1027-1031	most	_
6-17	1032-1041	perturbed	_
6-18	1042-1045	for	_
6-19	1046-1053	shorter	_
6-20	1054-1065	connections	_
6-21	1066-1074	implying	_
6-22	1075-1090	region-specific	_
6-23	1091-1101	disruption	_
6-24	1102-1104	by	_
6-25	1105-1107	CB	_
6-26	1108-1111	use	_
6-27	1112-1113	.	_

7-1	1114-1123	Rich-club	_
7-2	1124-1132	analysis	_
7-3	1133-1141	revealed	_
7-4	1142-1150	impaired	_
7-5	1151-1172	structural-functional	_
7-6	1173-1181	coupling	_
7-7	1182-1184	in	_
7-8	1185-1188	the	_
7-9	1189-1200	hippocampus	_
7-10	1201-1204	and	_
7-11	1205-1212	caudate	_
7-12	1213-1215	of	_
7-13	1216-1221	users	_
7-14	1222-1223	.	_

8-1	1224-1228	This	_
8-2	1229-1234	study	_
8-3	1235-1243	provides	_
8-4	1244-1252	evidence	_
8-5	1253-1255	of	_
8-6	1256-1259	the	_
8-7	1260-1268	abnormal	_
8-8	1269-1290	structural-functional	_
8-9	1291-1302	association	_
8-10	1303-1305	in	_
8-11	1306-1308	CB	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
8-12	1309-1314	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
8-13	1315-1316	.	_

9-1	1317-1320	The	_
9-2	1321-1327	effect	_
9-3	1328-1331	was	_
9-4	1332-1343	predominant	_
9-5	1344-1346	in	_
9-6	1347-1354	shorter	_
9-7	1355-1366	connections	_
9-8	1367-1369	of	_
9-9	1370-1373	the	_
9-10	1374-1379	brain	_
9-11	1380-1387	network	_
9-12	1388-1389	,	_
9-13	1390-1400	suggesting	_
9-14	1401-1405	that	_
9-15	1406-1409	the	_
9-16	1410-1416	impact	_
9-17	1417-1419	of	_
9-18	1420-1422	CB	_
9-19	1423-1426	use	_
9-20	1427-1429	or	_
9-21	1430-1446	predispositional	_
9-22	1447-1454	factors	_
9-23	1455-1458	may	_
9-24	1459-1461	be	_
9-25	1462-1466	most	_
9-26	1467-1475	apparent	_
9-27	1476-1478	in	_
9-28	1479-1484	local	_
9-29	1485-1501	interconnections	_
9-30	1502-1503	.	_

10-1	1504-1511	Notably	_
10-2	1512-1513	,	_
10-3	1514-1517	the	_
10-4	1518-1529	hippocampus	_
10-5	1530-1533	and	_
10-6	1534-1541	caudate	_
10-7	1542-1554	specifically	_
10-8	1555-1561	showed	_
10-9	1562-1570	aberrant	_
10-10	1571-1581	structural	_
10-11	1582-1585	and	_
10-12	1586-1596	functional	_
10-13	1597-1605	coupling	_
10-14	1606-1607	.	_

11-1	1608-1613	These	_
11-2	1614-1624	structures	_
11-3	1625-1629	have	_
11-4	1630-1634	high	_
11-5	1635-1638	CB1	_
11-6	1639-1647	receptor	_
11-7	1648-1655	density	_
11-8	1656-1659	and	_
11-9	1660-1663	may	_
11-10	1664-1668	also	_
11-11	1669-1671	be	_
11-12	1672-1682	associated	_
11-13	1683-1687	with	_
11-14	1688-1695	changes	_
11-15	1696-1698	in	_
11-16	1699-1707	learning	_
11-17	1708-1711	and	_
11-18	1712-1717	habit	_
11-19	1718-1727	formation	_
11-20	1728-1732	that	_
11-21	1733-1738	occur	_
11-22	1739-1743	with	_
11-23	1744-1751	chronic	_
11-24	1752-1760	cannabis	_
11-25	1761-1764	use	_
11-26	1765-1766	.	_

12-1	1767-1776	MATERIALS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	1777-1780	AND	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	1781-1788	METHODS	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	1789-1801	Participants	_
12-5	1802-1814	Participants	_
12-6	1815-1819	were	_
12-7	1820-1829	recruited	_
12-8	1830-1834	from	_
12-9	1835-1838	the	_
12-10	1839-1846	Indiana	_
12-11	1847-1857	University	_
12-12	1858-1864	campus	_
12-13	1865-1868	and	_
12-14	1869-1872	the	_
12-15	1873-1884	surrounding	_
12-16	1885-1894	community	_
12-17	1895-1902	through	_
12-18	1903-1909	flyers	_
12-19	1910-1913	and	_
12-20	1914-1928	advertisements	_
12-21	1929-1931	in	_
12-22	1932-1937	local	_
12-23	1938-1950	publications	_
12-24	1951-1952	.	_

13-1	1953-1961	Subjects	_
13-2	1962-1965	who	_
13-3	1966-1972	passed	_
13-4	1973-1975	an	_
13-5	1976-1983	initial	_
13-6	1984-1989	phone	_
13-7	1990-1996	screen	_
13-8	1997-2001	they	_
13-9	2002-2006	were	_
13-10	2007-2014	invited	_
13-11	2015-2019	into	_
13-12	2020-2023	the	_
13-13	2024-2034	laboratory	_
13-14	2035-2038	for	_
13-15	2039-2049	assessment	_
13-16	2050-2051	.	_

14-1	2052-2060	Subjects	_
14-2	2061-2066	first	_
14-3	2067-2075	provided	_
14-4	2076-2082	verbal	_
14-5	2083-2086	and	_
14-6	2087-2094	written	_
14-7	2095-2103	informed	_
14-8	2104-2111	consent	_
14-9	2112-2113	,	_
14-10	2114-2119	after	_
14-11	2120-2125	which	_
14-12	2126-2137	demographic	_
14-13	2138-2139	,	_
14-14	2140-2149	cognitive	_
14-15	2150-2151	,	_
14-16	2152-2165	questionnaire	_
14-17	2166-2167	,	_
14-18	2168-2177	substance	_
14-19	2178-2181	use	_
14-20	2182-2193	information	_
14-21	2194-2197	and	_
14-22	2198-2199	a	_
14-23	2200-2210	diagnostic	_
14-24	2211-2220	interview	_
14-25	2221-2225	were	_
14-26	2226-2234	obtained	_
14-27	2235-2236	.	_

15-1	2237-2240	All	_
15-2	2241-2249	subjects	_
15-3	2250-2254	were	_
15-4	2255-2263	required	_
15-5	2264-2266	to	_
15-6	2267-2269	be	_
15-7	2270-2272	18	_
15-8	2273-2278	years	_
15-9	2279-2281	of	_
15-10	2282-2285	age	_
15-11	2286-2288	or	_
15-12	2289-2294	older	_
15-13	2295-2296	,	_
15-14	2297-2300	and	_
15-15	2301-2305	free	_
15-16	2306-2308	of	_
15-17	2309-2312	any	_
15-18	2313-2325	neurological	_
15-19	2326-2334	disorder	_
15-20	2335-2336	,	_
15-21	2337-2341	head	_
15-22	2342-2348	trauma	_
15-23	2349-2353	with	_
15-24	2354-2358	loss	_
15-25	2359-2361	of	_
15-26	2362-2375	consciousness	_
15-27	2376-2383	greater	_
15-28	2384-2388	than	_
15-29	2389-2392	ten	_
15-30	2393-2400	minutes	_
15-31	2401-2402	,	_
15-32	2403-2411	learning	_
15-33	2412-2422	disability	_
15-34	2423-2424	,	_
15-35	2425-2428	and	_
15-36	2429-2445	contraindication	_
15-37	2446-2448	to	_
15-38	2449-2452	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
15-39	2453-2454	.	_

16-1	2455-2462	Subject	_
16-2	2463-2474	demographic	_
16-3	2475-2486	information	_
16-4	2487-2489	is	_
16-5	2490-2498	provided	_
16-6	2499-2501	in	_
16-7	2502-2507	Table	_
16-8	2508-2509	1	_
16-9	2510-2511	.	_

17-1	2512-2515	The	_
17-2	2516-2524	research	_
17-3	2525-2533	protocol	_
17-4	2534-2537	was	_
17-5	2538-2546	approved	_
17-6	2547-2549	by	_
17-7	2550-2557	Indiana	_
17-8	2558-2568	University	_
17-9	2569-2570	’	_
17-10	2571-2572	s	_
17-11	2573-2586	Institutional	_
17-12	2587-2593	Review	_
17-13	2594-2599	Board	_
17-14	2600-2603	for	_
17-15	2604-2607	the	_
17-16	2608-2618	protection	_
17-17	2619-2621	of	_
17-18	2622-2627	human	_
17-19	2628-2636	subjects	_
17-20	2637-2638	.	_

18-1	2639-2649	Thirty-one	_
18-2	2650-2657	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-3	2658-2665	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-4	2666-2674	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-5	2675-2682	without	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-6	2683-2694	psychiatric	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-7	2695-2704	disorders	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
18-8	2705-2709	were	_
18-9	2710-2719	recruited	_
18-10	2720-2721	.	_

19-1	2722-2731	Exclusion	_
19-2	2732-2740	criteria	_
19-3	2741-2749	included	_
19-4	2750-2757	absence	_
19-5	2758-2760	of	_
19-6	2761-2763	an	_
19-7	2764-2768	Axis	_
19-8	2769-2770	I	_
19-9	2771-2779	disorder	_
19-10	2780-2781	,	_
19-11	2782-2783	a	_
19-12	2784-2791	history	_
19-13	2792-2794	of	_
19-14	2795-2804	substance	_
19-15	2805-2810	abuse	_
19-16	2811-2813	or	_
19-17	2814-2824	dependence	_
19-18	2825-2826	,	_
19-19	2827-2828	a	_
19-20	2829-2837	positive	_
19-21	2838-2843	urine	_
19-22	2844-2850	screen	_
19-23	2851-2854	for	_
19-24	2855-2857	CB	_
19-25	2858-2860	or	_
19-26	2861-2866	other	_
19-27	2867-2877	substances	_
19-28	2878-2879	,	_
19-29	2880-2883	use	_
19-30	2884-2886	of	_
19-31	2887-2889	CB	_
19-32	2890-2892	in	_
19-33	2893-2896	the	_
19-34	2897-2901	past	_
19-35	2902-2907	three	_
19-36	2908-2914	months	_
19-37	2915-2918	and	_
19-38	2919-2923	more	_
19-39	2924-2928	than	_
19-40	2929-2931	12	_
19-41	2932-2940	lifetime	_
19-42	2941-2950	exposures	_
19-43	2951-2953	to	_
19-44	2954-2956	CB	_
19-45	2957-2958	(	_
19-46	2959-2963	mean	_
19-47	2964-2972	lifetime	_
19-48	2973-2982	exposures	_
19-49	2983-2984	=	_
19-50	2985-2988	0.8	_
19-51	2989-2990	)	_
19-52	2991-2992	.	_

20-1	2993-2996	All	_
20-2	2997-3004	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
20-3	3005-3017	participants	_
20-4	3018-3022	were	_
20-5	3023-3034	interviewed	_
20-6	3035-3040	using	_
20-7	3041-3044	the	_
20-8	3045-3052	SCID-NP	_
20-9	3053-3054	(	_
20-10	3055-3066	non-patient	_
20-11	3067-3074	version	_
20-12	3075-3076	)	_
20-13	3077-3079	to	_
20-14	3080-3087	exclude	_
20-15	3088-3099	individuals	_
20-16	3100-3104	with	_
20-17	3105-3116	psychiatric	_
20-18	3117-3126	diagnoses	_
20-19	3127-3128	.	_

21-1	3129-3141	Thirty-seven	_
21-2	3142-3149	current	_
21-3	3150-3152	CB	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
21-4	3153-3158	users	http://maven.renci.org/NeuroBridge/neurobridge#CocaineAbuse
21-5	3159-3163	were	_
21-6	3164-3173	recruited	_
21-7	3174-3177	who	_
21-8	3178-3182	were	_
21-9	3183-3191	recently	_
21-10	3192-3197	using	_
21-11	3198-3200	CB	_
21-12	3201-3203	at	_
21-13	3204-3209	least	_
21-14	3210-3214	once	_
21-15	3215-3218	per	_
21-16	3219-3223	week	_
21-17	3224-3225	,	_
21-18	3226-3230	with	_
21-19	3231-3235	mean	_
21-20	3236-3243	monthly	_
21-21	3244-3252	exposure	_
21-22	3253-3255	of	_
21-23	3256-3260	32.6	_
21-24	3261-3264	and	_
21-25	3265-3273	lifetime	_
21-26	3274-3283	exposures	_
21-27	3284-3285	>	_
21-28	3286-3288	45	_
21-29	3289-3290	.	_

22-1	3291-3294	All	_
22-2	3295-3300	users	_
22-3	3301-3305	were	_
22-4	3306-3310	free	_
22-5	3311-3315	from	_
22-6	3316-3319	the	_
22-7	3320-3327	current	_
22-8	3328-3332	Axis	_
22-9	3333-3334	I	_
22-10	3335-3344	disorders	_
22-11	3345-3348	and	_
22-12	3349-3352	any	_
22-13	3353-3358	other	_
22-14	3359-3366	illicit	_
22-15	3367-3376	substance	_
22-16	3377-3382	abuse	_
22-17	3383-3385	or	_
22-18	3386-3396	dependence	_
22-19	3397-3402	other	_
22-20	3403-3407	than	_
22-21	3408-3410	CB	_
22-22	3411-3414	use	_
22-23	3415-3424	disorders	_
22-24	3425-3426	.	_

23-1	3427-3438	Psychiatric	_
23-2	3439-3448	diagnoses	_
23-3	3449-3453	were	_
23-4	3454-3465	ascertained	_
23-5	3466-3470	with	_
23-6	3471-3474	the	_
23-7	3475-3485	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-8	3486-3494	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-9	3495-3504	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-10	3505-3508	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-11	3509-3518	DSM-IV-TR	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-12	3519-3520	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
23-13	3521-3527	SCID-I	_
23-14	3528-3529	)	_
23-15	3530-3538	Research	_
23-16	3539-3546	Version	_
23-17	3547-3548	.	_

24-1	3549-3550	A	_
24-2	3551-3558	written	_
24-3	3559-3563	drug	_
24-4	3564-3567	use	_
24-5	3568-3581	questionnaire	_
24-6	3582-3585	and	_
24-7	3586-3587	a	_
24-8	3588-3597	six-month	_
24-9	3598-3602	time	_
24-10	3603-3607	line	_
24-11	3608-3614	follow	_
24-12	3615-3619	back	_
24-13	3620-3630	assessment	_
24-14	3631-3634	was	_
24-15	3635-3639	used	_
24-16	3640-3642	to	_
24-17	3643-3651	estimate	_
24-18	3652-3658	recent	_
24-19	3659-3662	and	_
24-20	3663-3667	past	_
24-21	3668-3671	use	_
24-22	3672-3674	of	_
24-23	3675-3677	CB	_
24-24	3678-3679	.	_

25-1	3680-3685	Three	_
25-2	3686-3695	variables	_
25-3	3696-3710	characterizing	_
25-4	3711-3714	use	_
25-5	3715-3717	of	_
25-6	3718-3720	CB	_
25-7	3721-3725	were	_
25-8	3726-3732	chosen	_
25-9	3733-3736	for	_
25-10	3737-3748	statistical	_
25-11	3749-3757	analyses	_
25-12	3758-3759	:	_
25-13	3760-3763	age	_
25-14	3764-3766	of	_
25-15	3767-3772	onset	_
25-16	3773-3775	of	_
25-17	3776-3781	first	_
25-18	3782-3784	CB	_
25-19	3785-3788	use	_
25-20	3789-3790	,	_
25-21	3791-3799	lifetime	_
25-22	3800-3806	number	_
25-23	3807-3809	of	_
25-24	3810-3819	exposures	_
25-25	3820-3822	to	_
25-26	3823-3825	CB	_
25-27	3826-3827	,	_
25-28	3828-3831	and	_
25-29	3832-3838	number	_
25-30	3839-3841	of	_
25-31	3842-3851	exposures	_
25-32	3852-3854	to	_
25-33	3855-3857	CB	_
25-34	3858-3860	in	_
25-35	3861-3864	the	_
25-36	3865-3869	past	_
25-37	3870-3875	month	_
25-38	3876-3877	.	_

26-1	3878-3882	Both	_
26-2	3883-3886	age	_
26-3	3887-3889	of	_
26-4	3890-3895	onset	_
26-5	3896-3899	and	_
26-6	3900-3905	total	_
26-7	3906-3914	lifetime	_
26-8	3915-3924	exposures	_
26-9	3925-3929	have	_
26-10	3930-3934	been	_
26-11	3935-3945	associated	_
26-12	3946-3950	with	_
26-13	3951-3955	risk	_
26-14	3956-3959	for	_
26-15	3960-3970	subsequent	_
26-16	3971-3980	psychotic	_
26-17	3981-3990	disorders	_
26-18	3991-3992	,	_
26-19	3993-3996	and	_
26-20	3997-4001	thus	_
26-21	4002-4011	represent	_
26-22	4012-4021	potential	_
26-23	4022-4032	predictors	_
26-24	4033-4035	of	_
26-25	4036-4041	brain	_
26-26	4042-4049	network	_
26-27	4050-4057	changes	_
26-28	4058-4064	linked	_
26-29	4065-4069	with	_
26-30	4070-4083	vulnerability	_
26-31	4084-4086	to	_
26-32	4087-4096	psychosis	_
26-33	4097-4098	.	_

27-1	4099-4101	CB	_
27-2	4102-4105	use	_
27-3	4106-4108	in	_
27-4	4109-4112	the	_
27-5	4113-4117	past	_
27-6	4118-4123	month	_
27-7	4124-4132	assessed	_
27-8	4133-4141	possible	_
27-9	4142-4149	effects	_
27-10	4150-4152	of	_
27-11	4153-4155	CB	_
27-12	4156-4167	metabolites	_
27-13	4168-4170	on	_
27-14	4171-4176	brain	_
27-15	4177-4189	connectivity	_
27-16	4190-4191	.	_

28-1	4192-4195	The	_
28-2	4196-4204	Wechsler	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-3	4205-4216	Abbreviated	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-4	4217-4222	Scale	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-5	4223-4225	of	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-6	4226-4238	Intelligence	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-7	4239-4240	(	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-8	4241-4245	WASI	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-9	4246-4247	)	http://maven.renci.org/NeuroBridge/neurobridge#DigitSymbolSubstitutionOfTheWechslerAdultIntelligenceScaleRevised
28-10	4248-4251	was	_
28-11	4252-4264	administered	_
28-12	4265-4267	to	_
28-13	4268-4276	estimate	_
28-14	4277-4286	currently	_
28-15	4287-4299	intellectual	_
28-16	4300-4308	function	_
28-17	4309-4310	.	_

29-1	4311-4317	Groups	_
29-2	4318-4321	did	_
29-3	4322-4325	not	_
29-4	4326-4339	significantly	_
29-5	4340-4346	differ	_
29-6	4347-4349	in	_
29-7	4350-4353	age	_
29-8	4354-4355	,	_
29-9	4356-4358	IQ	_
29-10	4359-4360	,	_
29-11	4361-4368	alcohol	_
29-12	4369-4372	use	_
29-13	4373-4374	,	_
29-14	4375-4381	gender	_
29-15	4382-4384	or	_
29-16	4385-4389	race	_
29-17	4390-4391	(	_
29-18	4392-4393	p	_
29-19	4394-4395	>	_
29-20	4396-4400	0.05	_
29-21	4401-4402	)	_
29-22	4403-4404	;	_
29-23	4405-4412	however	_
29-24	4413-4414	,	_
29-25	4415-4418	the	_
29-26	4419-4421	CB	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
29-27	4422-4427	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
29-28	4428-4431	had	_
29-29	4432-4437	fewer	_
29-30	4438-4443	years	_
29-31	4444-4446	of	_
29-32	4447-4456	education	_
29-33	4457-4458	(	_
29-34	4459-4463	14.0	_
29-35	4464-4467	vs.	_
29-36	4468-4472	15.4	_
29-37	4473-4478	years	_
29-38	4479-4480	;	_
29-39	4481-4486	Table	_
29-40	4487-4488	1	_
29-41	4489-4490	)	_
29-42	4491-4492	.	_

30-1	4493-4501	Subjects	_
30-2	4502-4506	were	_
30-3	4507-4512	asked	_
30-4	4513-4515	to	_
30-5	4516-4523	refrain	_
30-6	4524-4528	from	_
30-7	4529-4536	alcohol	_
30-8	4537-4539	or	_
30-9	4540-4542	CB	_
30-10	4543-4546	use	_
30-11	4547-4552	prior	_
30-12	4553-4555	to	_
30-13	4556-4559	the	_
30-14	4560-4563	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
30-15	4564-4568	scan	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
30-16	4569-4570	.	_

31-1	4571-4573	At	_
31-2	4574-4583	screening	_
31-3	4584-4585	,	_
31-4	4586-4588	11	_
31-5	4589-4597	subjects	_
31-6	4598-4599	(	_
31-7	4600-4609	including	_
31-8	4610-4611	1	_
31-9	4612-4619	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
31-10	4620-4627	subject	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
31-11	4628-4629	)	_
31-12	4630-4640	identified	_
31-13	4641-4651	themselves	_
31-14	4652-4654	as	_
31-15	4655-4656	a	_
31-16	4657-4663	smoker	_
31-17	4664-4666	on	_
31-18	4667-4670	the	_
31-19	4671-4681	Fagerstrom	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
31-20	4682-4690	Nicotine	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
31-21	4691-4701	Dependence	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
31-22	4702-4715	Questionnaire	http://maven.renci.org/NeuroBridge/neurobridge#FagerstromTestforNicotineDependence
31-23	4716-4717	,	_
31-24	4718-4720	of	_
31-25	4721-4726	which	_
31-26	4727-4731	only	_
31-27	4732-4733	3	_
31-28	4734-4742	subjects	_
31-29	4743-4744	(	_
31-30	4745-4752	without	_
31-31	4753-4761	controls	_
31-32	4762-4763	)	_
31-33	4764-4770	scored	_
31-34	4771-4776	above	_
31-35	4777-4778	a	_
31-36	4779-4783	zero	_
31-37	4784-4785	(	_
31-38	4786-4789	two	_
31-39	4790-4796	scored	_
31-40	4797-4798	a	_
31-41	4799-4800	1	_
31-42	4801-4804	and	_
31-43	4805-4808	one	_
31-44	4809-4815	scored	_
31-45	4816-4817	a	_
31-46	4818-4819	2	_
31-47	4820-4821	)	_
31-48	4822-4823	,	_
31-49	4824-4829	which	_
31-50	4830-4832	is	_
31-51	4833-4843	indicative	_
31-52	4844-4846	of	_
31-53	4847-4848	“	_
31-54	4849-4853	very	_
31-55	4854-4857	low	_
31-56	4858-4868	dependence	_
31-57	4869-4870	”	_
31-58	4871-4872	.	_

32-1	4873-4875	At	_
32-2	4876-4879	the	_
32-3	4880-4884	time	_
32-4	4885-4887	of	_
32-5	4888-4891	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
32-6	4892-4896	scan	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
32-7	4897-4898	,	_
32-8	4899-4903	nine	_
32-9	4904-4912	subjects	_
32-10	4913-4926	self-reported	_
32-11	4927-4935	nicotine	_
32-12	4936-4939	use	_
32-13	4940-4946	within	_
32-14	4947-4950	the	_
32-15	4951-4955	past	_
32-16	4956-4957	7	_
32-17	4958-4962	days	_
32-18	4963-4964	.	_

33-1	4965-4968	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
33-2	4969-4980	Acquisition	_
33-3	4981-4986	Image	_
33-4	4987-4998	acquisition	_
33-5	4999-5002	was	_
33-6	5003-5012	performed	_
33-7	5013-5015	on	_
33-8	5016-5017	a	_
33-9	5018-5020	3T	http://maven.renci.org/NeuroBridge/neurobridge#Thing
33-10	5021-5028	Siemens	_
33-11	5029-5037	Tim-Trio	_
33-12	5038-5041	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
33-13	5042-5049	scanner	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
33-14	5050-5051	.	_

34-1	5052-5056	Foam	_
34-2	5057-5061	pads	_
34-3	5062-5066	were	_
34-4	5067-5071	used	_
34-5	5072-5074	to	_
34-6	5075-5083	minimize	_
34-7	5084-5088	head	_
34-8	5089-5095	motion	_
34-9	5096-5099	for	_
34-10	5100-5103	all	_
34-11	5104-5116	participants	_
34-12	5117-5118	.	_

35-1	5119-5129	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
35-2	5130-5135	scans	_
35-3	5136-5140	were	_
35-4	5141-5149	acquired	_
35-5	5150-5155	using	_
35-6	5156-5157	a	_
35-7	5158-5169	single-shot	http://maven.renci.org/NeuroBridge/neurobridge#SinglePhotonImaging
35-8	5170-5189	echo-planar-imaging	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
35-9	5190-5191	(	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
35-10	5192-5198	SS-EPI	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
35-11	5199-5200	)	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
35-12	5201-5209	sequence	_
35-13	5210-5211	[	_
35-14	5212-5222	repetition	_
35-15	5223-5227	time	_
35-16	5228-5229	(	_
35-17	5230-5232	TR	_
35-18	5233-5234	)	_
35-19	5235-5236	=	_
35-20	5237-5240	813	_
35-21	5241-5243	ms	_
35-22	5244-5245	;	_
35-23	5246-5250	echo	_
35-24	5251-5255	time	_
35-25	5256-5257	(	_
35-26	5258-5260	TE	_
35-27	5261-5262	)	_
35-28	5263-5264	=	_
35-29	5265-5267	28	_
35-30	5268-5270	ms	_
35-31	5271-5272	;	_
35-32	5273-5277	flip	_
35-33	5278-5283	angle	_
35-34	5284-5285	=	_
35-35	5286-5289	60°	_
35-36	5290-5291	;	_
35-37	5292-5294	42	_
35-38	5295-5305	transverse	_
35-39	5306-5312	slices	_
35-40	5313-5314	;	_
35-41	5315-5320	slice	_
35-42	5321-5330	thickness	_
35-43	5331-5334	3.4	_
35-44	5335-5337	mm	_
35-45	5338-5339	;	_
35-46	5340-5345	field	_
35-47	5346-5348	of	_
35-48	5349-5353	view	_
35-49	5354-5355	(	_
35-50	5356-5359	FOV	_
35-51	5360-5361	)	_
35-52	5362-5363	=	_
35-53	5364-5371	220×220	_
35-54	5372-5375	mm2	_
35-55	5376-5377	;	_
35-56	5378-5385	imaging	_
35-57	5386-5392	matrix	_
35-58	5393-5394	=	_
35-59	5395-5400	64×64	_
35-60	5401-5402	;	_
35-61	5403-5411	in-plane	_
35-62	5412-5417	voxel	_
35-63	5418-5422	size	_
35-64	5423-5424	=	_
35-65	5425-5434	3.44×3.44	_
35-66	5435-5438	mm2	_
35-67	5439-5440	]	_
35-68	5441-5442	.	_

36-1	5443-5451	Subjects	_
36-2	5452-5456	were	_
36-3	5457-5467	instructed	_
36-4	5468-5470	to	_
36-5	5471-5475	rest	_
36-6	5476-5478	in	_
36-7	5479-5482	the	_
36-8	5483-5490	scanner	_
36-9	5491-5498	looking	_
36-10	5499-5501	at	_
36-11	5502-5503	a	_
36-12	5504-5518	fixation-cross	_
36-13	5519-5521	on	_
36-14	5522-5523	a	_
36-15	5524-5530	screen	_
36-16	5531-5534	via	_
36-17	5535-5537	an	_
36-18	5538-5541	LCD	_
36-19	5542-5551	projector	_
36-20	5552-5553	.	_

37-1	5554-5559	Scans	_
37-2	5560-5563	for	_
37-3	5564-5567	the	_
37-4	5568-5573	first	_
37-5	5574-5576	10	_
37-6	5577-5580	sec	_
37-7	5581-5585	were	_
37-8	5586-5595	discarded	_
37-9	5596-5598	to	_
37-10	5599-5604	allow	_
37-11	5605-5608	the	_
37-12	5609-5625	T1-magnetisation	_
37-13	5626-5637	equilibrium	_
37-14	5638-5639	,	_
37-15	5640-5649	resulting	_
37-16	5650-5652	in	_
37-17	5653-5654	a	_
37-18	5655-5660	total	_
37-19	5661-5663	of	_
37-20	5664-5668	1000	_
37-21	5669-5676	volumes	_
37-22	5677-5678	(	_
37-23	5679-5680	=	_
37-24	5681-5683	14	_
37-25	5684-5687	min	_
37-26	5688-5689	)	_
37-27	5690-5691	.	_

38-1	5692-5695	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
38-2	5696-5701	scans	_
38-3	5702-5706	were	_
38-4	5707-5715	obtained	_
38-5	5716-5717	(	_
38-6	5718-5719	=	_
38-7	5720-5721	6	_
38-8	5722-5725	min	_
38-9	5726-5728	24	_
38-10	5729-5732	sec	_
38-11	5733-5734	)	_
38-12	5735-5740	using	_
38-13	5741-5747	SS-EPI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
38-14	5748-5756	sequence	_
38-15	5757-5758	[	_
38-16	5759-5761	TR	_
38-17	5762-5763	=	_
38-18	5764-5767	4.5	_
38-19	5768-5769	s	_
38-20	5770-5771	;	_
38-21	5772-5774	TE	_
38-22	5775-5776	=	_
38-23	5777-5779	88	_
38-24	5780-5782	ms	_
38-25	5783-5784	;	_
38-26	5785-5789	flip	_
38-27	5790-5795	angle	_
38-28	5796-5797	=	_
38-29	5798-5801	90°	_
38-30	5802-5803	;	_
38-31	5804-5806	72	_
38-32	5807-5817	transverse	_
38-33	5818-5824	slices	_
38-34	5825-5826	;	_
38-35	5827-5832	slice	_
38-36	5833-5842	thickness	_
38-37	5843-5844	2	_
38-38	5845-5847	mm	_
38-39	5848-5849	;	_
38-40	5850-5853	FOV	_
38-41	5854-5855	=	_
38-42	5856-5863	256×256	_
38-43	5864-5867	mm2	_
38-44	5868-5869	;	_
38-45	5870-5877	imaging	_
38-46	5878-5884	matrix	_
38-47	5885-5886	=	_
38-48	5887-5894	128×128	_
38-49	5895-5896	;	_
38-50	5897-5905	in-plane	_
38-51	5906-5911	voxel	_
38-52	5912-5916	size	_
38-53	5917-5918	=	_
38-54	5919-5922	2×2	_
38-55	5923-5926	mm2	_
38-56	5927-5928	;	_
38-57	5929-5931	64	_
38-58	5932-5945	non-collinear	_
38-59	5946-5956	directions	_
38-60	5957-5958	;	_
38-61	5959-5966	b-value	_
38-62	5967-5969	of	_
38-63	5970-5975	1,000	_
38-64	5976-5981	s/mm2	_
38-65	5982-5983	;	_
38-66	5984-5985	8	_
38-67	5986-5988	b0	_
38-68	5989-5995	images	_
38-69	5996-5997	]	_
38-70	5998-5999	.	_

39-1	6000-6003	DTI	http://maven.renci.org/NeuroBridge/neurobridge#DifffusionTensorImaging
39-2	6004-6009	scans	_
39-3	6010-6014	were	_
39-4	6015-6023	repeated	_
39-5	6024-6029	twice	_
39-6	6030-6034	with	_
39-7	6035-6043	opposite	_
39-8	6044-6058	phase-encoding	_
39-9	6059-6069	directions	_
39-10	6070-6071	[	_
39-11	6072-6093	anterior-to-posterior	_
39-12	6094-6095	(	_
39-13	6096-6098	AP	_
39-14	6099-6100	)	_
39-15	6101-6104	and	_
39-16	6105-6126	posterior-to-anterior	_
39-17	6127-6128	(	_
39-18	6129-6131	PA	_
39-19	6132-6133	)	_
39-20	6134-6135	]	_
39-21	6136-6138	to	_
39-22	6139-6146	correct	_
39-23	6147-6159	eddy-current	_
39-24	6160-6163	and	_
39-25	6164-6178	susceptibility	_
39-26	6179-6186	induced	_
39-27	6187-6192	image	_
39-28	6193-6203	distortion	_
39-29	6204-6205	(	_
39-30	6206-6209	see	_
39-31	6210-6220	Structural	_
39-32	6221-6233	Connectivity	_
39-33	6234-6235	)	_
39-34	6236-6237	.	_

40-1	6238-6250	Subsequently	_
40-2	6251-6252	,	_
40-3	6253-6268	high-resolution	http://maven.renci.org/NeuroBridge/neurobridge#HighRisk
40-4	6269-6280	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
40-5	6281-6291	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
40-6	6292-6298	images	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
40-7	6299-6303	were	_
40-8	6304-6312	acquired	_
40-9	6313-6315	in	_
40-10	6316-6319	the	_
40-11	6320-6328	sagittal	_
40-12	6329-6334	plane	_
40-13	6335-6340	using	_
40-14	6341-6343	an	_
40-15	6344-6362	inversion-recovery	_
40-16	6363-6370	spoiled	_
40-17	6371-6379	gradient	_
40-18	6380-6388	recalled	_
40-19	6389-6400	acquisition	_
40-20	6401-6402	(	_
40-21	6403-6410	IR-SPGR	_
40-22	6411-6412	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
40-23	6413-6421	sequence	_
40-24	6422-6423	[	_
40-25	6424-6426	TR	_
40-26	6427-6428	=	_
40-27	6429-6432	1.8	_
40-28	6433-6434	s	_
40-29	6435-6436	;	_
40-30	6437-6439	TE	_
40-31	6440-6441	=	_
40-32	6442-6443	2	_
40-33	6444-6445	.	_

41-1	6446-6448	67	_
41-2	6449-6451	ms	_
41-3	6452-6453	;	_
41-4	6454-6463	inversion	_
41-5	6464-6468	time	_
41-6	6469-6470	=	_
41-7	6471-6474	0.9	_
41-8	6475-6476	s	_
41-9	6477-6478	;	_
41-10	6479-6483	flip	_
41-11	6484-6489	angle	_
41-12	6490-6492	9°	_
41-13	6493-6494	;	_
41-14	6495-6502	imaging	_
41-15	6503-6509	matrix	_
41-16	6510-6511	=	_
41-17	6512-6519	256×256	_
41-18	6520-6521	;	_
41-19	6522-6525	192	_
41-20	6526-6532	slices	_
41-21	6533-6534	;	_
41-22	6535-6540	voxel	_
41-23	6541-6545	size	_
41-24	6546-6547	=	_
41-25	6548-6553	1×1×1	_
41-26	6554-6557	mm3	_
41-27	6558-6559	]	_
41-28	6560-6561	.	_

42-1	6562-6565	All	_
42-2	6566-6571	scans	_
42-3	6572-6576	were	_
42-4	6577-6585	visually	_
42-5	6586-6593	checked	_
42-6	6594-6596	to	_
42-7	6597-6603	ensure	_
42-8	6604-6614	acceptable	_
42-9	6615-6618	MRI	_
42-10	6619-6626	quality	_
42-11	6627-6628	.	_

43-1	6629-6639	Anatomical	_
43-2	6640-6652	Parcellation	_
43-3	6653-6666	Preprocessing	_
43-4	6667-6669	of	_
43-5	6670-6681	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-6	6682-6685	MRI	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-7	6686-6689	was	_
43-8	6690-6699	performed	_
43-9	6700-6705	using	_
43-10	6706-6716	Freesurfer	_
43-11	6717-6718	(	_
43-12	6719-6723	http	_
43-13	6724-6725	:	_
43-14	6726-6742	//freesurfer.net	_
43-15	6743-6744	)	_
43-16	6745-6746	.	_

44-1	6747-6750	The	_
44-2	6751-6759	cortical	_
44-3	6760-6767	regions	_
44-4	6768-6772	were	_
44-5	6773-6784	parcellated	_
44-6	6785-6789	into	_
44-7	6790-6802	anatomically	_
44-8	6803-6811	distinct	_
44-9	6812-6814	68	_
44-10	6815-6823	cortical	_
44-11	6824-6827	and	_
44-12	6828-6830	14	_
44-13	6831-6842	subcortical	_
44-14	6843-6850	regions	_
44-15	6851-6856	using	_
44-16	6857-6873	Desikan-Killiany	_
44-17	6874-6879	atlas	_
44-18	6880-6881	,	_
44-19	6882-6885	and	_
44-20	6886-6899	automatically	_
44-21	6900-6910	subdivided	_
44-22	6911-6915	into	_
44-23	6916-6917	a	_
44-24	6918-6921	set	_
44-25	6922-6924	of	_
44-26	6925-6929	1014	_
44-27	6930-6937	smaller	_
44-28	6938-6945	regions	_
44-29	6946-6947	,	_
44-30	6948-6952	each	_
44-31	6953-6955	of	_
44-32	6956-6961	which	_
44-33	6962-6965	was	_
44-34	6966-6967	a	_
44-35	6968-6975	network	_
44-36	6976-6980	node	_
44-37	6981-6982	(	_
44-38	6983-6989	Figure	_
44-39	6990-6993	S1A	_
44-40	6994-6995	)	_
44-41	6996-7001	using	_
44-42	7002-7012	Connectome	_
44-43	7013-7019	Mapper	_
44-44	7020-7021	.	_

45-1	7022-7026	This	_
45-2	7027-7035	approach	_
45-3	7036-7044	resulted	_
45-4	7045-7047	in	_
45-5	7048-7061	approximately	_
45-6	7062-7071	identical	_
45-7	7072-7076	node	_
45-8	7077-7082	sizes	_
45-9	7083-7089	across	_
45-10	7090-7094	both	_
45-11	7095-7106	hemispheres	_
45-12	7107-7108	[	_
45-13	7109-7113	mean	_
45-14	7114-7115	±	_
45-15	7116-7118	SD	_
45-16	7119-7120	=	_
45-17	7121-7125	0.68	_
45-18	7126-7127	±	_
45-19	7128-7131	0.3	_
45-20	7132-7135	cm3	_
45-21	7136-7137	]	_
45-22	7138-7139	.	_

46-1	7140-7143	DTI	_
46-2	7144-7157	Preprocessing	_
46-3	7158-7161	DTI	_
46-4	7162-7172	distortion	_
46-5	7173-7183	correction	_
46-6	7184-7187	was	_
46-7	7188-7197	performed	_
46-8	7198-7203	using	_
46-9	7204-7207	the	_
46-10	7208-7211	FSL	_
46-11	7212-7219	toolbox	_
46-12	7220-7221	(	_
46-13	7222-7226	http	_
46-14	7227-7228	:	_
46-15	7229-7261	//fsl.fmrib.ox.ac.uk/fsl/fslwiki	_
46-16	7262-7263	)	_
46-17	7264-7265	.	_

47-1	7266-7288	Susceptibility-induced	_
47-2	7289-7302	off-resonance	_
47-3	7303-7308	field	_
47-4	7309-7312	was	_
47-5	7313-7322	estimated	_
47-6	7323-7328	using	_
47-7	7329-7332	two	_
47-8	7333-7345	acquisitions	_
47-9	7346-7350	with	_
47-10	7351-7359	opposing	_
47-11	7360-7370	polarities	_
47-12	7371-7373	of	_
47-13	7374-7377	the	_
47-14	7378-7390	phase-encode	_
47-15	7391-7396	blips	_
47-16	7397-7398	(	_
47-17	7399-7403	i.e.	_
47-18	7404-7405	,	_
47-19	7406-7408	AP	_
47-20	7409-7412	and	_
47-21	7413-7415	PA	_
47-22	7416-7426	directions	_
47-23	7427-7428	)	_
47-24	7429-7431	by	_
47-25	7432-7437	TOPUP	_
47-26	7438-7439	.	_

48-1	7440-7450	Correction	_
48-2	7451-7454	for	_
48-3	7455-7458	the	_
48-4	7459-7473	susceptibility	_
48-5	7474-7475	,	_
48-6	7476-7480	eddy	_
48-7	7481-7488	current	_
48-8	7489-7490	,	_
48-9	7491-7494	and	_
48-10	7495-7511	movement-related	_
48-11	7512-7517	image	_
48-12	7518-7529	distortions	_
48-13	7530-7534	were	_
48-14	7535-7544	performed	_
48-15	7545-7550	using	_
48-16	7551-7555	EDDY	_
48-17	7556-7557	.	_

49-1	7558-7560	No	_
49-2	7561-7572	significant	_
49-3	7573-7583	difference	_
49-4	7584-7591	between	_
49-5	7592-7598	groups	_
49-6	7599-7602	for	_
49-7	7603-7607	head	_
49-8	7608-7617	movements	_
49-9	7618-7621	was	_
49-10	7622-7627	found	_
49-11	7628-7629	(	_
49-12	7630-7634	mean	_
49-13	7635-7636	±	_
49-14	7637-7639	SD	_
49-15	7640-7642	in	_
49-16	7643-7645	mm	_
49-17	7646-7647	;	_
49-18	7648-7650	CB	_
49-19	7651-7652	:	_
49-20	7653-7656	1.0	_
49-21	7657-7658	±	_
49-22	7659-7662	0.4	_
49-23	7663-7664	;	_
49-24	7665-7667	HC	_
49-25	7668-7669	:	_
49-26	7670-7673	0.9	_
49-27	7674-7675	±	_
49-28	7676-7679	0.1	_
49-29	7680-7681	;	_
49-30	7682-7683	t	_
49-31	7684-7685	=	_
49-32	7686-7690	1.15	_
49-33	7691-7692	,	_
49-34	7693-7694	p	_
49-35	7695-7696	=	_
49-36	7697-7701	0.25	_
49-37	7702-7703	)	_
49-38	7704-7705	.	_

50-1	7706-7707	A	_
50-2	7708-7717	diffusion	_
50-3	7718-7724	tensor	_
50-4	7725-7728	was	_
50-5	7729-7735	fitted	_
50-6	7736-7738	at	_
50-7	7739-7743	each	_
50-8	7744-7749	voxel	_
50-9	7750-7755	using	_
50-10	7756-7765	nonlinear	_
50-11	7766-7775	iterative	_
50-12	7776-7782	method	_
50-13	7783-7785	to	_
50-14	7786-7791	avoid	_
50-15	7792-7800	negative	_
50-16	7801-7812	eigenvalues	_
50-17	7813-7814	,	_
50-18	7815-7818	and	_
50-19	7819-7822	its	_
50-20	7823-7834	directional	_
50-21	7835-7846	uncertainty	_
50-22	7847-7850	was	_
50-23	7851-7859	computed	_
50-24	7860-7865	using	_
50-25	7866-7867	a	_
50-26	7868-7877	100-times	_
50-27	7878-7887	jackknife	_
50-28	7888-7898	resampling	_
50-29	7899-7908	algorithm	_
50-30	7909-7910	.	_

51-1	7911-7916	Fiber	_
51-2	7917-7923	tracts	_
51-3	7924-7928	from	_
51-4	7929-7932	the	_
51-5	7933-7939	seeded	_
51-6	7940-7945	white	_
51-7	7946-7952	matter	_
51-8	7953-7960	regions	_
51-9	7961-7965	were	_
51-10	7966-7975	generated	_
51-11	7976-7981	using	_
51-12	7982-7985	the	_
51-13	7986-7999	probabilistic	_
51-14	8000-8009	algorithm	_
51-15	8010-8014	with	_
51-16	8015-8025	voxel-wise	_
51-17	8026-8037	directional	_
51-18	8038-8049	uncertainty	_
51-19	8050-8051	[	_
51-20	8052-8062	fractional	_
51-21	8063-8073	anisotropy	_
51-22	8074-8075	(	_
51-23	8076-8078	FA	_
51-24	8079-8080	)	_
51-25	8081-8082	>	_
51-26	8083-8086	0.1	_
51-27	8087-8088	;	_
51-28	8089-8098	direction	_
51-29	8099-8105	change	_
51-30	8106-8107	<	_
51-31	8108-8111	60°	_
51-32	8112-8113	;	_
51-33	8114-8119	tract	_
51-34	8120-8126	length	_
51-35	8127-8128	>	_
51-36	8129-8130	1	_
51-37	8131-8133	cm	_
51-38	8134-8135	;	_
51-39	8136-8138	30	_
51-40	8139-8144	seeds	_
51-41	8145-8148	per	_
51-42	8149-8154	voxel	_
51-43	8155-8156	;	_
51-44	8157-8162	1,000	_
51-45	8163-8174	Monte-Carlo	_
51-46	8175-8185	iterations	_
51-47	8186-8187	,	_
51-48	8188-8198	generating	_
51-49	8199-8205	30,000	_
51-50	8206-8212	trials	_
51-51	8213-8215	at	_
51-52	8216-8220	each	_
51-53	8221-8226	voxel	_
51-54	8227-8228	]	_
51-55	8229-8230	.	_

52-1	8231-8241	Consistent	_
52-2	8242-8246	with	_
52-3	8247-8255	previous	_
52-4	8256-8270	investigations	_
52-5	8271-8272	,	_
52-6	8273-8283	structural	_
52-7	8284-8296	connectivity	_
52-8	8297-8298	(	_
52-9	8299-8301	SC	_
52-10	8302-8303	)	_
52-11	8304-8311	between	_
52-12	8312-8315	any	_
52-13	8316-8320	pair	_
52-14	8321-8323	of	_
52-15	8324-8329	nodes	_
52-16	8330-8333	was	_
52-17	8334-8341	defined	_
52-18	8342-8344	as	_
52-19	8345-8346	a	_
52-20	8347-8357	normalized	_
52-21	8358-8364	weight	_
52-22	8365-8373	computed	_
52-23	8374-8376	by	_
52-24	8377-8380	the	_
52-25	8381-8387	number	_
52-26	8388-8390	of	_
52-27	8391-8402	streamlines	_
52-28	8403-8410	between	_
52-29	8411-8425	interconnected	_
52-30	8426-8433	regions	_
52-31	8434-8435	(	_
52-32	8436-8442	Figure	_
52-33	8443-8446	S1B	_
52-34	8447-8448	)	_
52-35	8449-8450	.	_

53-1	8451-8464	Resting-State	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
53-2	8465-8469	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
53-3	8470-8483	Preprocessing	_
53-4	8484-8497	Resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
53-5	8498-8502	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
53-6	8503-8506	was	_
53-7	8507-8519	preprocessed	_
53-8	8520-8527	similar	_
53-9	8528-8530	to	_
53-10	8531-8539	standard	_
53-11	8540-8550	functional	_
53-12	8551-8563	connectivity	_
53-13	8564-8577	preprocessing	_
53-14	8578-8583	using	_
53-15	8584-8588	AFNI	_
53-16	8589-8590	(	_
53-17	8591-8595	http	_
53-18	8596-8597	:	_
53-19	8598-8617	//afni.nimh.nih.gov	_
53-20	8618-8619	)	_
53-21	8620-8621	;	_
53-22	8622-8632	de-spiking	_
53-23	8633-8634	,	_
53-24	8635-8640	slice	_
53-25	8641-8647	timing	_
53-26	8648-8658	correction	_
53-27	8659-8660	,	_
53-28	8661-8667	motion	_
53-29	8668-8678	correction	_
53-30	8679-8680	,	_
53-31	8681-8694	normalization	_
53-32	8695-8697	to	_
53-33	8698-8699	a	_
53-34	8700-8709	Talairach	_
53-35	8710-8718	template	_
53-36	8719-8720	,	_
53-37	8721-8731	within-run	_
53-38	8732-8741	intensity	_
53-39	8742-8755	normalization	_
53-40	8756-8758	to	_
53-41	8759-8760	a	_
53-42	8761-8772	whole-brain	_
53-43	8773-8777	mode	_
53-44	8778-8783	value	_
53-45	8784-8786	of	_
53-46	8787-8791	1000	_
53-47	8792-8793	,	_
53-48	8794-8801	removal	_
53-49	8802-8804	of	_
53-50	8805-8813	nuisance	_
53-51	8814-8818	time	_
53-52	8819-8825	series	_
53-53	8826-8827	[	_
53-54	8828-8829	6	_
53-55	8830-8837	motions	_
53-56	8838-8839	,	_
53-57	8840-8845	white	_
53-58	8846-8852	matter	_
53-59	8853-8856	and	_
53-60	8857-8868	ventricular	_
53-61	8869-8876	signals	_
53-62	8877-8878	(	_
53-63	8879-8885	eroded	_
53-64	8886-8888	by	_
53-65	8889-8892	one	_
53-66	8893-8898	voxel	_
53-67	8899-8900	)	_
53-68	8901-8902	,	_
53-69	8903-8907	with	_
53-70	8908-8913	their	_
53-71	8914-8925	derivatives	_
53-72	8926-8927	]	_
53-73	8928-8933	using	_
53-74	8934-8940	linear	_
53-75	8941-8951	regression	_
53-76	8952-8953	,	_
53-77	8954-8962	temporal	_
53-78	8963-8972	band-pass	_
53-79	8973-8982	filtering	_
53-80	8983-8984	(	_
53-81	8985-8995	0.009–0.08	_
53-82	8996-8998	Hz	_
53-83	8999-9000	)	_
53-84	9001-9002	,	_
53-85	9003-9010	spatial	_
53-86	9011-9020	smoothing	_
53-87	9021-9025	only	_
53-88	9026-9028	in	_
53-89	9029-9032	the	_
53-90	9033-9037	gray	_
53-91	9038-9044	matter	_
53-92	9045-9049	mask	_
53-93	9050-9051	(	_
53-94	9052-9056	6-mm	_
53-95	9057-9061	full	_
53-96	9062-9067	width	_
53-97	9068-9070	at	_
53-98	9071-9075	half	_
53-99	9076-9083	maximum	_
53-100	9084-9085	)	_
53-101	9086-9087	.	_

54-1	9088-9089	A	_
54-2	9090-9095	whole	_
54-3	9096-9101	brain	_
54-4	9102-9108	signal	_
54-5	9109-9112	was	_
54-6	9113-9116	not	_
54-7	9117-9125	included	_
54-8	9126-9128	in	_
54-9	9129-9137	nuisance	_
54-10	9138-9148	covariates	_
54-11	9149-9154	given	_
54-12	9155-9163	on-going	_
54-13	9164-9175	controversy	_
54-14	9176-9185	regarding	_
54-15	9186-9189	its	_
54-16	9190-9195	value	_
54-17	9196-9197	.	_

55-1	9198-9205	Volumes	_
55-2	9206-9210	with	_
55-3	9211-9215	high	_
55-4	9216-9222	motion	_
55-5	9223-9227	were	_
55-6	9228-9236	censored	_
55-7	9237-9239	to	_
55-8	9240-9248	decrease	_
55-9	9249-9258	potential	_
55-10	9259-9273	motion-induced	_
55-11	9274-9278	bias	_
55-12	9279-9281	of	_
55-13	9282-9292	functional	_
55-14	9293-9305	connectivity	_
55-15	9306-9307	.	_

56-1	9308-9310	We	_
56-2	9311-9315	used	_
56-3	9316-9326	thresholds	_
56-4	9327-9331	with	_
56-5	9332-9333	a	_
56-6	9334-9344	frame-wise	_
56-7	9345-9357	displacement	_
56-8	9358-9359	(	_
56-9	9360-9362	FD	_
56-10	9363-9364	)	_
56-11	9365-9367	of	_
56-12	9368-9371	0.5	_
56-13	9372-9375	and	_
56-14	9376-9377	a	_
56-15	9378-9388	percentage	_
56-16	9389-9391	of	_
56-17	9392-9396	BOLD	_
56-18	9397-9403	signal	_
56-19	9404-9411	changes	_
56-20	9412-9416	over	_
56-21	9417-9420	the	_
56-22	9421-9426	whole	_
56-23	9427-9432	brain	_
56-24	9433-9435	of	_
56-25	9436-9439	0.5	_
56-26	9440-9441	,	_
56-27	9442-9447	above	_
56-28	9448-9453	which	_
56-29	9454-9459	scans	_
56-30	9460-9461	(	_
56-31	9462-9471	including	_
56-32	9472-9473	1	_
56-33	9474-9482	backward	_
56-34	9483-9486	and	_
56-35	9487-9488	2	_
56-36	9489-9496	forward	_
56-37	9497-9504	volumes	_
56-38	9505-9506	)	_
56-39	9507-9511	were	_
56-40	9512-9519	removed	_
56-41	9520-9521	.	_

57-1	9522-9524	No	_
57-2	9525-9536	significant	_
57-3	9537-9547	difference	_
57-4	9548-9551	was	_
57-5	9552-9557	found	_
57-6	9558-9560	in	_
57-7	9561-9564	the	_
57-8	9565-9571	number	_
57-9	9572-9574	of	_
57-10	9575-9583	censored	_
57-11	9584-9591	volumes	_
57-12	9592-9596	from	_
57-13	9597-9602	1,000	_
57-14	9603-9616	resting-state	_
57-15	9617-9622	scans	_
57-16	9623-9630	between	_
57-17	9631-9634	two	_
57-18	9635-9641	groups	_
57-19	9642-9643	(	_
57-20	9644-9648	mean	_
57-21	9649-9650	±	_
57-22	9651-9653	SD	_
57-23	9654-9655	;	_
57-24	9656-9658	CB	_
57-25	9659-9660	:	_
57-26	9661-9665	32.2	_
57-27	9666-9667	±	_
57-28	9668-9672	76.6	_
57-29	9673-9674	;	_
57-30	9675-9677	HC	_
57-31	9678-9679	:	_
57-32	9680-9684	17.2	_
57-33	9685-9686	±	_
57-34	9687-9691	26.0	_
57-35	9692-9693	;	_
57-36	9694-9695	t	_
57-37	9696-9697	=	_
57-38	9698-9702	0.47	_
57-39	9703-9704	,	_
57-40	9705-9706	p	_
57-41	9707-9708	=	_
57-42	9709-9713	0.64	_
57-43	9714-9715	)	_
57-44	9716-9717	.	_

58-1	9718-9728	Structural	_
58-2	9729-9732	and	_
58-3	9733-9743	Functional	_
58-4	9744-9756	Connectivity	_
58-5	9757-9767	Consistent	_
58-6	9768-9772	with	_
58-7	9773-9781	previous	_
58-8	9782-9796	investigations	_
58-9	9797-9798	,	_
58-10	9799-9809	structural	_
58-11	9810-9822	connectivity	_
58-12	9823-9824	(	_
58-13	9825-9827	SC	_
58-14	9828-9829	)	_
58-15	9830-9837	between	_
58-16	9838-9841	any	_
58-17	9842-9846	pair	_
58-18	9847-9849	of	_
58-19	9850-9855	nodes	_
58-20	9856-9859	was	_
58-21	9860-9867	defined	_
58-22	9868-9870	as	_
58-23	9871-9872	a	_
58-24	9873-9883	normalized	_
58-25	9884-9890	weight	_
58-26	9891-9899	computed	_
58-27	9900-9902	by	_
58-28	9903-9906	the	_
58-29	9907-9913	number	_
58-30	9914-9916	of	_
58-31	9917-9928	streamlines	_
58-32	9929-9936	between	_
58-33	9937-9951	interconnected	_
58-34	9952-9959	regions	_
58-35	9960-9961	(	_
58-36	9962-9968	Figure	_
58-37	9969-9972	S1B	_
58-38	9973-9974	)	_
58-39	9975-9976	.	_

59-1	9977-9987	Functional	_
59-2	9988-10000	connectivity	_
59-3	10001-10002	(	_
59-4	10003-10005	FC	_
59-5	10006-10007	)	_
59-6	10008-10011	was	_
59-7	10012-10021	estimated	_
59-8	10022-10027	using	_
59-9	10028-10035	Pearson	_
59-10	10036-10037	’	_
59-11	10038-10039	s	_
59-12	10040-10051	correlation	_
59-13	10052-10063	coefficient	_
59-14	10064-10065	(	_
59-15	10066-10067	r	_
59-16	10068-10069	)	_
59-17	10070-10077	between	_
59-18	10078-10082	mean	_
59-19	10083-10087	BOLD	_
59-20	10088-10099	time-series	_
59-21	10100-10104	from	_
59-22	10105-10108	all	_
59-23	10109-10114	pairs	_
59-24	10115-10117	of	_
59-25	10118-10122	1014	_
59-26	10123-10128	brain	_
59-27	10129-10136	regions	_
59-28	10137-10140	and	_
59-29	10141-10150	converted	_
59-30	10151-10153	to	_
59-31	10154-10162	z-scores	_
59-32	10163-10168	using	_
59-33	10169-10175	Fisher	_
59-34	10176-10177	’	_
59-35	10178-10179	s	_
59-36	10180-10186	r-to-z	_
59-37	10187-10201	transformation	_
59-38	10202-10203	(	_
59-39	10204-10210	Figure	_
59-40	10211-10214	S1B	_
59-41	10215-10216	)	_
59-42	10217-10218	.	_

60-1	10219-10240	Structural-Functional	_
60-2	10241-10249	Coupling	_
60-3	10250-10253	All	_
60-4	10254-10261	nonzero	_
60-5	10262-10270	elements	_
60-6	10271-10273	of	_
60-7	10274-10277	the	_
60-8	10278-10288	structural	_
60-9	10289-10301	connectivity	_
60-10	10302-10308	matrix	_
60-11	10309-10310	(	_
60-12	10311-10315	i.e.	_
60-13	10316-10317	,	_
60-14	10318-10321	the	_
60-15	10322-10327	upper	_
60-16	10328-10338	triangular	_
60-17	10339-10343	part	_
60-18	10344-10346	of	_
60-19	10347-10358	1,014×1,014	_
60-20	10359-10361	SC	_
60-21	10362-10368	matrix	_
60-22	10369-10370	)	_
60-23	10371-10375	were	_
60-24	10376-10385	extracted	_
60-25	10386-10389	and	_
60-26	10390-10398	rescaled	_
60-27	10399-10401	to	_
60-28	10402-10403	a	_
60-29	10404-10412	Gaussian	_
60-30	10413-10425	distribution	_
60-31	10426-10427	(	_
60-32	10428-10432	mean	_
60-33	10433-10434	±	_
60-34	10435-10437	SD	_
60-35	10438-10439	=	_
60-36	10440-10443	0.5	_
60-37	10444-10445	±	_
60-38	10446-10449	0.1	_
60-39	10450-10451	)	_
60-40	10452-10453	.	_

61-1	10454-10458	This	_
61-2	10459-10468	rescaling	_
61-3	10469-10473	step	_
61-4	10474-10477	was	_
61-5	10478-10487	motivated	_
61-6	10488-10490	by	_
61-7	10491-10494	the	_
61-8	10495-10506	observation	_
61-9	10507-10511	that	_
61-10	10512-10522	structural	_
61-11	10523-10535	connectivity	_
61-12	10536-10543	weights	_
61-13	10544-10552	computed	_
61-14	10553-10557	from	_
61-15	10558-10568	streamline	_
61-16	10569-10575	counts	_
61-17	10576-10581	often	_
61-18	10582-10587	shows	_
61-19	10588-10589	a	_
61-20	10590-10596	highly	_
61-21	10597-10603	skewed	_
61-22	10604-10605	(	_
61-23	10606-10610	e.g.	_
61-24	10611-10612	,	_
61-25	10613-10624	exponential	_
61-26	10625-10626	)	_
61-27	10627-10639	distribution	_
61-28	10640-10641	,	_
61-29	10642-10647	which	_
61-30	10648-10650	is	_
61-31	10651-10659	unlikely	_
61-32	10660-10662	to	_
61-33	10663-10670	reflect	_
61-34	10671-10686	physiologically	_
61-35	10687-10697	meaningful	_
61-36	10698-10706	coupling	_
61-37	10707-10715	strength	_
61-38	10716-10717	;	_
61-39	10718-10727	rescaling	_
61-40	10728-10737	preserves	_
61-41	10738-10741	the	_
61-42	10742-10746	rank	_
61-43	10747-10752	order	_
61-44	10753-10755	of	_
61-45	10756-10761	tract	_
61-46	10762-10769	weights	_
61-47	10770-10771	.	_

62-1	10772-10780	Coupling	_
62-2	10781-10788	between	_
62-3	10789-10799	structural	_
62-4	10800-10812	connectivity	_
62-5	10813-10816	and	_
62-6	10817-10820	its	_
62-7	10821-10831	functional	_
62-8	10832-10844	counterparts	_
62-9	10845-10848	was	_
62-10	10849-10857	computed	_
62-11	10858-10860	as	_
62-12	10861-10862	a	_
62-13	10863-10870	Pearson	_
62-14	10871-10872	’	_
62-15	10873-10874	s	_
62-16	10875-10886	correlation	_
62-17	10887-10898	coefficient	_
62-18	10899-10906	between	_
62-19	10907-10912	these	_
62-20	10913-10916	two	_
62-21	10917-10925	measures	_
62-22	10926-10927	.	_

63-1	10928-10933	While	_
63-2	10934-10937	the	_
63-3	10938-10959	structural–functional	_
63-4	10960-10968	coupling	_
63-5	10969-10972	was	_
63-6	10973-10982	decreased	_
63-7	10983-10985	in	_
63-8	10986-10990	some	_
63-9	10991-10998	disease	_
63-10	10999-11005	states	_
63-11	11006-11018	representing	_
63-12	11019-11020	a	_
63-13	11021-11029	progress	_
63-14	11030-11032	of	_
63-15	11033-11036	the	_
63-16	11037-11052	disease-related	_
63-17	11053-11074	structural–functional	_
63-18	11075-11085	impairment	_
63-19	11086-11087	,	_
63-20	11088-11090	it	_
63-21	11091-11094	has	_
63-22	11095-11099	also	_
63-23	11100-11104	been	_
63-24	11105-11114	suggested	_
63-25	11115-11117	to	_
63-26	11118-11120	be	_
63-27	11121-11130	increased	_
63-28	11131-11133	in	_
63-29	11134-11138	more	_
63-30	11139-11148	stringent	_
63-31	11149-11159	functional	_
63-32	11160-11171	interaction	_
63-33	11172-11182	restrained	_
63-34	11183-11187	with	_
63-35	11188-11198	underlying	_
63-36	11199-11209	anatomical	_
63-37	11210-11221	connections	_
63-38	11222-11232	reflecting	_
63-39	11233-11237	both	_
63-40	11238-11241	the	_
63-41	11242-11248	normal	_
63-42	11249-11260	development	_
63-43	11261-11264	and	_
63-44	11265-11268	the	_
63-45	11269-11276	disease	_
63-46	11277-11278	.	_

64-1	11279-11287	Distance	_
64-2	11288-11298	Dependence	_
64-3	11299-11301	of	_
64-4	11302-11314	Connectivity	_
64-5	11315-11323	Measures	_
64-6	11324-11326	As	_
64-7	11327-11336	described	_
64-8	11337-11347	previously	_
64-9	11348-11349	,	_
64-10	11350-11362	associations	_
64-11	11363-11370	between	_
64-12	11371-11374	the	_
64-13	11375-11385	connection	_
64-14	11386-11394	distance	_
64-15	11395-11396	(	_
64-16	11397-11405	measured	_
64-17	11406-11408	by	_
64-18	11409-11414	fiber	_
64-19	11415-11423	distance	_
64-20	11424-11431	between	_
64-21	11432-11435	two	_
64-22	11436-11443	regions	_
64-23	11444-11445	)	_
64-24	11446-11449	and	_
64-25	11450-11462	connectivity	_
64-26	11463-11471	measures	_
64-27	11472-11476	were	_
64-28	11477-11485	computed	_
64-29	11486-11487	,	_
64-30	11488-11490	in	_
64-31	11491-11496	which	_
64-32	11497-11505	distance	_
64-33	11506-11514	measures	_
64-34	11515-11519	were	_
64-35	11520-11529	converted	_
64-36	11530-11532	to	_
64-37	11533-11536	the	_
64-38	11537-11552	log-transformed	_
64-39	11553-11561	distance	_
64-40	11562-11565	for	_
64-41	11566-11568	SC	_
64-42	11569-11572	and	_
64-43	11573-11576	the	_
64-44	11577-11584	inverse	_
64-45	11585-11587	of	_
64-46	11588-11591	the	_
64-47	11592-11597	fiber	_
64-48	11598-11606	distance	_
64-49	11607-11614	between	_
64-50	11615-11622	regions	_
64-51	11623-11626	for	_
64-52	11627-11629	FC	_
64-53	11630-11631	,	_
64-54	11632-11644	respectively	_
64-55	11645-11646	.	_

65-1	11647-11654	Network	_
65-2	11655-11670	Characteristics	_
65-3	11671-11673	To	_
65-4	11674-11685	investigate	_
65-5	11686-11696	structural	_
65-6	11697-11707	substrates	_
65-7	11708-11710	of	_
65-8	11711-11714	the	_
65-9	11715-11720	SC-FC	_
65-10	11721-11729	coupling	_
65-11	11730-11737	between	_
65-12	11738-11741	two	_
65-13	11742-11748	groups	_
65-14	11749-11750	,	_
65-15	11751-11757	global	_
65-16	11758-11765	network	_
65-17	11766-11776	properties	_
65-18	11777-11779	of	_
65-19	11780-11783	the	_
65-20	11784-11794	structural	_
65-21	11795-11807	connectivity	_
65-22	11808-11812	were	_
65-23	11813-11825	additionally	_
65-24	11826-11834	computed	_
65-25	11835-11840	using	_
65-26	11841-11844	the	_
65-27	11845-11850	Brain	_
65-28	11851-11863	Connectivity	_
65-29	11864-11871	Toolbox	_
65-30	11872-11873	(	_
65-31	11874-11879	https	_
65-32	11880-11881	:	_
65-33	11882-11912	//sites.google.com/site/bctnet	_
65-34	11913-11914	)	_
65-35	11915-11916	,	_
65-36	11917-11922	which	_
65-37	11923-11931	collects	_
65-38	11932-11946	representative	_
65-39	11947-11955	measures	_
65-40	11956-11959	for	_
65-41	11960-11967	network	_
65-42	11968-11979	integration	_
65-43	11980-11981	[	_
65-44	11982-11996	characteristic	_
65-45	11997-12001	path	_
65-46	12002-12008	length	_
65-47	12009-12010	(	_
65-48	12011-12012	λ	_
65-49	12013-12014	)	_
65-50	12015-12018	and	_
65-51	12019-12025	global	_
65-52	12026-12036	efficiency	_
65-53	12037-12038	(	_
65-54	12039-12041	GE	_
65-55	12042-12043	)	_
65-56	12044-12045	]	_
65-57	12046-12047	,	_
65-58	12048-12059	segregation	_
65-59	12060-12061	[	_
65-60	12062-12072	clustering	_
65-61	12073-12084	coefficient	_
65-62	12085-12086	(	_
65-63	12087-12088	γ	_
65-64	12089-12090	)	_
65-65	12091-12094	and	_
65-66	12095-12105	modularity	_
65-67	12106-12107	(	_
65-68	12108-12109	Q	_
65-69	12110-12111	)	_
65-70	12112-12113	]	_
65-71	12114-12115	,	_
65-72	12116-12119	and	_
65-73	12120-12125	their	_
65-74	12126-12137	combination	_
65-75	12138-12140	or	_
65-76	12141-12148	balance	_
65-77	12149-12150	[	_
65-78	12151-12166	small-worldness	_
65-79	12167-12168	(	_
65-80	12169-12170	σ	_
65-81	12171-12172	)	_
65-82	12173-12174	]	_
65-83	12175-12176	.	_

66-1	12177-12179	To	_
66-2	12180-12187	compute	_
66-3	12188-12198	normalized	_
66-4	12199-12207	measures	_
66-5	12208-12209	[	_
66-6	12210-12214	i.e.	_
66-7	12215-12216	,	_
66-8	12217-12231	characteristic	_
66-9	12232-12236	path	_
66-10	12237-12243	length	_
66-11	12244-12245	(	_
66-12	12246-12247	λ	_
66-13	12248-12249	)	_
66-14	12250-12251	,	_
66-15	12252-12258	global	_
66-16	12259-12269	efficiency	_
66-17	12270-12271	(	_
66-18	12272-12274	GE	_
66-19	12275-12276	)	_
66-20	12277-12278	,	_
66-21	12279-12289	clustering	_
66-22	12290-12301	coefficient	_
66-23	12302-12303	(	_
66-24	12304-12305	γ	_
66-25	12306-12307	)	_
66-26	12308-12311	and	_
66-27	12312-12327	small-worldness	_
66-28	12328-12329	(	_
66-29	12330-12331	σ	_
66-30	12332-12333	)	_
66-31	12334-12335	]	_
66-32	12336-12337	,	_
66-33	12338-12342	1000	_
66-34	12343-12352	instances	_
66-35	12353-12355	of	_
66-36	12356-12364	randomly	_
66-37	12365-12372	rewired	_
66-38	12373-12377	null	_
66-39	12378-12383	model	_
66-40	12384-12392	matrices	_
66-41	12393-12394	(	_
66-42	12395-12405	preserving	_
66-43	12406-12409	the	_
66-44	12410-12421	connections	_
66-45	12422-12429	weights	_
66-46	12430-12431	,	_
66-47	12432-12435	the	_
66-48	12436-12442	number	_
66-49	12443-12445	of	_
66-50	12446-12457	connections	_
66-51	12458-12459	,	_
66-52	12460-12465	edges	_
66-53	12466-12467	,	_
66-54	12468-12471	and	_
66-55	12472-12478	degree	_
66-56	12479-12488	sequences	_
66-57	12489-12490	)	_
66-58	12491-12495	were	_
66-59	12496-12505	generated	_
66-60	12506-12507	.	_

67-1	12508-12517	Rich-club	_
67-2	12518-12530	Organization	_
67-3	12531-12533	To	_
67-4	12534-12546	subsequently	_
67-5	12547-12554	examine	_
67-6	12555-12558	the	_
67-7	12559-12567	regional	_
67-8	12568-12574	impact	_
67-9	12575-12577	of	_
67-10	12578-12583	SC-FC	_
67-11	12584-12592	coupling	_
67-12	12593-12594	,	_
67-13	12595-12596	a	_
67-14	12597-12606	rich-club	_
67-15	12607-12608	(	_
67-16	12609-12611	RC	_
67-17	12612-12613	)	_
67-18	12614-12616	in	_
67-19	12617-12620	the	_
67-20	12621-12631	structural	_
67-21	12632-12639	network	_
67-22	12640-12643	was	_
67-23	12644-12651	defined	_
67-24	12652-12654	as	_
67-25	12655-12656	a	_
67-26	12657-12660	set	_
67-27	12661-12663	of	_
67-28	12664-12675	high-degree	_
67-29	12676-12677	(	_
67-30	12678-12682	i.e.	_
67-31	12683-12684	,	_
67-32	12685-12686	“	_
67-33	12687-12691	rich	_
67-34	12692-12693	”	_
67-35	12694-12695	)	_
67-36	12696-12701	nodes	_
67-37	12702-12707	which	_
67-38	12708-12712	were	_
67-39	12713-12717	also	_
67-40	12718-12725	densely	_
67-41	12726-12740	interconnected	_
67-42	12741-12742	,	_
67-43	12743-12747	more	_
67-44	12748-12750	so	_
67-45	12751-12755	than	_
67-46	12756-12764	expected	_
67-47	12765-12770	based	_
67-48	12771-12773	on	_
67-49	12774-12775	a	_
67-50	12776-12782	random	_
67-51	12783-12787	null	_
67-52	12788-12793	model	_
67-53	12794-12795	.	_

68-1	12796-12804	Weighted	_
68-2	12805-12807	RC	_
68-3	12808-12820	organization	_
68-4	12821-12824	was	_
68-5	12825-12835	quantified	_
68-6	12836-12839	for	_
68-7	12840-12844	each	_
68-8	12845-12855	individual	_
68-9	12856-12857	.	_

69-1	12858-12863	After	_
69-2	12864-12867	all	_
69-3	12868-12875	weights	_
69-4	12876-12877	(	_
69-5	12878-12879	w	_
69-6	12880-12881	)	_
69-7	12882-12884	in	_
69-8	12885-12888	the	_
69-9	12889-12891	SC	_
69-10	12892-12898	matrix	_
69-11	12899-12903	were	_
69-12	12904-12910	ranked	_
69-13	12911-12912	(	_
69-14	12913-12920	wranked	_
69-15	12921-12922	)	_
69-16	12923-12924	,	_
69-17	12925-12928	the	_
69-18	12929-12937	weighted	_
69-19	12938-12940	RC	_
69-20	12941-12952	coefficient	_
69-21	12953-12954	(	_
69-22	12955-12956	𝜙	_
69-23	12957-12958	)	_
69-24	12959-12962	was	_
69-25	12963-12971	computed	_
69-26	12972-12974	as	_
69-27	12975-12976	a	_
69-28	12977-12985	function	_
69-29	12986-12988	of	_
69-30	12989-12993	node	_
69-31	12994-13000	degree	_
69-32	13001-13002	(	_
69-33	13003-13004	k	_
69-34	13005-13006	:	_
69-35	13007-13010	the	_
69-36	13011-13017	number	_
69-37	13018-13020	of	_
69-38	13021-13032	connections	_
69-39	13033-13035	at	_
69-40	13036-13040	each	_
69-41	13041-13045	node	_
69-42	13046-13047	)	_
69-43	13048-13050	by	_
69-44	13051-13052	,	_
69-45	13053-13055	in	_
69-46	13056-13061	which	_
69-47	13062-13063	W	_
69-48	13064-13065	>	_
69-49	13066-13067	k	_
69-50	13068-13071	and	_
69-51	13072-13073	E	_
69-52	13074-13075	>	_
69-53	13076-13077	k	_
69-54	13078-13082	mean	_
69-55	13083-13086	the	_
69-56	13087-13090	sum	_
69-57	13091-13093	of	_
69-58	13094-13101	weights	_
69-59	13102-13105	and	_
69-60	13106-13109	the	_
69-61	13110-13116	number	_
69-62	13117-13119	of	_
69-63	13120-13131	connections	_
69-64	13132-13135	for	_
69-65	13136-13137	>	_
69-66	13138-13139	k	_
69-67	13140-13145	nodes	_
69-68	13146-13147	,	_
69-69	13148-13160	respectively	_
69-70	13161-13162	.	_

70-1	13163-13166	The	_
70-2	13167-13175	computed	_
70-3	13176-13178	RC	_
70-4	13179-13190	coefficient	_
70-5	13191-13192	,	_
70-6	13193-13194	ϕ	_
70-7	13195-13196	(	_
70-8	13197-13198	k	_
70-9	13199-13200	)	_
70-10	13201-13202	,	_
70-11	13203-13206	was	_
70-12	13207-13217	normalized	_
70-13	13218-13220	to	_
70-14	13221-13224	the	_
70-15	13225-13229	mean	_
70-16	13230-13232	RC	_
70-17	13233-13244	coefficient	_
70-18	13245-13249	from	_
70-19	13250-13255	1,000	_
70-20	13256-13262	random	_
70-21	13263-13267	null	_
70-22	13268-13276	matrices	_
70-23	13277-13279	to	_
70-24	13280-13284	test	_
70-25	13285-13292	whether	_
70-26	13293-13296	the	_
70-27	13297-13303	actual	_
70-28	13304-13311	density	_
70-29	13312-13314	of	_
70-30	13315-13331	interconnections	_
70-31	13332-13345	significantly	_
70-32	13346-13354	exceeded	_
70-33	13355-13359	that	_
70-34	13360-13362	of	_
70-35	13363-13366	the	_
70-36	13367-13371	null	_
70-37	13372-13377	model	_
70-38	13378-13379	.	_

71-1	13380-13387	Because	_
71-2	13388-13391	the	_
71-3	13392-13398	degree	_
71-4	13399-13412	distributions	_
71-5	13413-13415	of	_
71-6	13416-13419	the	_
71-7	13420-13422	SC	_
71-8	13423-13431	matrices	_
71-9	13432-13440	differed	_
71-10	13441-13447	across	_
71-11	13448-13459	individuals	_
71-12	13460-13461	,	_
71-13	13462-13465	all	_
71-14	13466-13470	node	_
71-15	13471-13478	degrees	_
71-16	13479-13483	were	_
71-17	13484-13494	normalized	_
71-18	13495-13497	to	_
71-19	13498-13503	allow	_
71-20	13504-13507	the	_
71-21	13508-13518	comparison	_
71-22	13519-13521	of	_
71-23	13522-13533	equal-sized	_
71-24	13534-13542	networks	_
71-25	13543-13546	for	_
71-26	13547-13549	CB	_
71-27	13550-13555	users	_
71-28	13556-13559	and	_
71-29	13560-13567	healthy	_
71-30	13568-13577	non-users	_
71-31	13578-13579	(	_
71-32	13580-13586	Figure	_
71-33	13587-13590	S1C	_
71-34	13591-13592	)	_
71-35	13593-13594	.	_

72-1	13595-13599	From	_
72-2	13600-13603	the	_
72-3	13604-13614	normalized	_
72-4	13615-13621	degree	_
72-5	13622-13634	distribution	_
72-6	13635-13641	across	_
72-7	13642-13645	the	_
72-8	13646-13654	subjects	_
72-9	13655-13656	,	_
72-10	13657-13659	we	_
72-11	13660-13667	defined	_
72-12	13668-13670	RC	_
72-13	13671-13678	regions	_
72-14	13679-13683	with	_
72-15	13684-13687	the	_
72-16	13688-13691	top	_
72-17	13692-13694	10	_
72-18	13695-13696	%	_
72-19	13697-13701	node	_
72-20	13702-13708	degree	_
72-21	13709-13710	(	_
72-22	13711-13712	>	_
72-23	13713-13715	32	_
72-24	13716-13717	)	_
72-25	13718-13720	as	_
72-26	13721-13723	in	_
72-27	13724-13727	the	_
72-28	13728-13736	previous	_
72-29	13737-13744	studies	_
72-30	13745-13756	Statistical	_
72-31	13757-13765	Analysis	_
72-32	13766-13779	Nonparametric	_
72-33	13780-13790	randomized	_
72-34	13791-13802	permutation	_
72-35	13803-13810	testing	_
72-36	13811-13812	(	_
72-37	13813-13819	10,000	_
72-38	13820-13832	permutations	_
72-39	13833-13834	)	_
72-40	13835-13838	was	_
72-41	13839-13843	used	_
72-42	13844-13847	for	_
72-43	13848-13853	group	_
72-44	13854-13865	comparisons	_
72-45	13866-13869	for	_
72-46	13870-13876	global	_
72-47	13877-13880	and	_
72-48	13881-13889	regional	_
72-49	13890-13895	SC-FC	_
72-50	13896-13904	coupling	_
72-51	13905-13906	,	_
72-52	13907-13909	RC	_
72-53	13910-13921	coefficient	_
72-54	13922-13923	,	_
72-55	13924-13927	and	_
72-56	13928-13935	network	_
72-57	13936-13943	metrics	_
72-58	13944-13945	.	_

73-1	13946-13949	The	_
73-2	13950-13962	associations	_
73-3	13963-13970	between	_
73-4	13971-13976	SC-FC	_
73-5	13977-13985	coupling	_
73-6	13986-13989	and	_
73-7	13990-13997	network	_
73-8	13998-14005	metrics	_
73-9	14006-14010	were	_
73-10	14011-14019	compared	_
73-11	14020-14025	using	_
73-12	14026-14027	a	_
73-13	14028-14038	two-tailed	_
73-14	14039-14045	Fisher	_
73-15	14046-14047	’	_
73-16	14048-14049	s	_
73-17	14050-14056	z-test	_
73-18	14057-14061	with	_
73-19	14062-14077	false-discovery	_
73-20	14078-14082	rate	_
73-21	14083-14084	(	_
73-22	14085-14088	FDR	_
73-23	14089-14090	)	_
73-24	14091-14100	corrected	_
73-25	14101-14102	p	_
73-26	14103-14104	<	_
73-27	14105-14109	0.05	_
73-28	14110-14111	.	_

74-1	14112-14123	Statistical	_
74-2	14124-14135	comparisons	_
74-3	14136-14143	between	_
74-4	14144-14150	groups	_
74-5	14151-14158	include	_
74-6	14159-14170	educational	_
74-7	14171-14177	length	_
74-8	14178-14179	,	_
74-9	14180-14183	age	_
74-10	14184-14185	,	_
74-11	14186-14189	sex	_
74-12	14190-14191	,	_
74-13	14192-14195	and	_
74-14	14196-14203	alcohol	_
74-15	14204-14207	use	_
74-16	14208-14210	as	_
74-17	14211-14221	covariates	_
74-18	14222-14223	.	_

